Program

Please see below for details of both Sunday and Monday's program:

 

SUNDAY 23rd JUNE, 2019

08:30

Welcome and Opening Remarks

Richard L. Schilsky, MD., FACP, FASCO, FSCT

Chairman WIN Consortium, American Society of Clinical Oncology (ASCO®), USA

Josep Tabernero, MD, PhD

Vice-Chairman WIN Consortium, Vall d’Hebron Institute of Oncology (VHIO), Spain, President European Society for Medical Oncology (ESMO), Switzerland

 09:00

Opening Keynote Lecture
Lifestyle-based Prevention Strategies

Jennifer A. Ligibel, MD

Harvard Medical School, Dana Farber Cancer Institute, USA

PRESIDENTIAL SESSION 1: TRANSFORMATIVE INNOVATIONS IN PRECISION ONCOLOGY TRIALS AND CHALLENGES OF EXPERIMENTAL THERAPEUTICS
Chairs:
Richard L. Schilsky, ASCO®, USA, Chairman of WIN Consortium
Josep Tabernero, ESMO, Vice Chairman of WIN Consortium

 09:30

Presidential Lecture

Rewriting the Code of Life:  CRISPR-Cas Genome Editing

Jennifer A. Doudna, PhD

University of California, Berkeley, USA

 10:00

Keynote Lecture    

Innovation in Clinical Trials: WINTHER trial

Razelle Kurzrock, MD

University of California, San Diego (UCSD), USA

 10:30

Coffee Break, Networking

 11:00

Keynote Lecture:

Optimizing Patient Enrollment and Efficacy of Precision Oncology Clinical Trials

Apostolia-Maria Tsimberidou, MD., PhD

 

University of Texas MD Anderson Cancer Center, Houston, Texas, USA

11:30

Innovation in Clinical Trials: SPRING_01 Proof of Concept Trial exploring Combination of Three Targeted Drugs

Benjamin Solomon, MD

Avera Cancer Institute, Sioux Falls, USA

12:00

Systems Immunology in IO: A view from the Parker Institute

Nikesh Kotecha, PhD

Parker Institute for Cancer Immunotherapy, USA

12:25

Panel Discussion

Moderators:
Session's chairs

13:00

Lunch, poster viewing and networking

SESSION 2: SYSTEMS BIOLOGY APPROACHES FOR PRECISION ONCOLOGY
Chairs:
Brian Leyland Jones, WIN Consortium
Vladimir Lazar, Chief Scientific and Operating Officer WIN Consortium

14:00

Gene expression in primary non-small cell lung cancer as a predictor of brain metastasis

Jair Bar

Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel

14:20

Efficient In Vitro Screening for Drug Combinations: The TEVA Model

Angel Porgador, PhD

Ben Gurion University of the Negev, Israel

14:40

Keynote Lecture 

Innovative Ways of Assessing Durable Response to Immunotherapy 

Christophe Le Tourneau, MD., PhD

Institut Curie, France

15:00

Addressing Mechanisms of Resistance Following Anti-Cancer Therapy: a Pharma Perspective

Jean-François Martini, PhD., MSc

Pfizer Inc., USA

15:20

Panel Discussion

Moderators:
Session's Chairs

15:40

Coffee Break, Networking

16:00

Micro Satellite Symposium 1: Real-World Evidence and its Relevance for Clinical Practice and Stakeholder Decision Making

17:00

Micro Satellite Symposium 2: Artificial Intelligence to Support Patient Profiling in Precision Oncology

18:00

Welcome reception, networking and poster viewing

20:00

Gala Dinner

WIN 2019 Symposium
c/o MCI UK Ltd
Durford Mill
Petersfield
GU31 5AZ

Tel: +44 (0) 1730 715223
General enquiries: win2019@mci-group.com
Sponsorship enquiries: win2019industry@mci-group.com
Abstract enquiries: win2019abstracts@mci-group.com
Registration enquiries: win2019reg@mci-group.com

View Our Privacy Policy Here